Defining a Reference Set to Support Methodological Research in Drug Safety

Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership

(2013) Paul E. Stang et al.   ANNALS OF INTERNAL MEDICINE

Empirical Performance of the Calibrated Self-Controlled Cohort Analysis Within Temporal Pattern Discovery: Lessons for Developing a Risk Identification and Analysis System

(2013) G. Niklas Norén et al.   DRUG SAFETY

Assessment of Case Definitions for Identifying Acute Liver Injury in Large Observational Databases

(2013) Aaron J. Katz et al.   DRUG SAFETY

Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis

(2012) R Harpaz et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection Using Electronic Healthcare Record Databases

(2012) Preciosa M. Coloma et al.   DRUG SAFETY

Using Electronic Health Care Records for Drug Safety Signal Detection

(2012) Martijn J. Schuemie et al.   MEDICAL CARE

Consistency in the safety labeling of bioequivalent medications

(2012) Jon Duke et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Electronic healthcare databases for active drug safety surveillance: is there enough leverage?

(2012) Preciosa M. Coloma et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership

(2012) Patrick B. Ryan et al.   STATISTICS IN MEDICINE

A Quantitative Analysis of Adverse Events and “Overwarning” in Drug Labeling

(2011) Jon Duke   ARCHIVES OF INTERNAL MEDICINE

Rosiglitazone Revisited

(2010) Steven E. Nissen et al.   ARCHIVES OF INTERNAL MEDICINE

Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding

(2010) Elvira L. Massó González et al.   ARTHRITIS AND RHEUMATISM

Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community

(2010) Arduino A. Mangoni et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Clinical features and risk factors for upper gastrointestinal bleeding in children: a case-crossover study

(2010) Lamiae Grimaldi-Bensouda et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD

(2010) Martijn J. Schuemie   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure

(2009) David W Ouyang et al.   AIDS

Selective Serotonin Reuptake Inhibitors Are Associated With a Modest Increase in the Risk of Upper Gastrointestinal Bleeding

(2009) Laura E Targownik et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Acute Renal Failure and Its Risk Factors in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

(2009) Chi-Chih Hung et al.   AMERICAN JOURNAL OF NEPHROLOGY

Temporal pattern discovery in longitudinal electronic patient records

(2009) G. Niklas Norén et al.   DATA MINING AND KNOWLEDGE DISCOVERY

Risk of Upper Gastrointestinal Bleeding and the Degree of Serotonin Reuptake Inhibition by Antidepressants

(2009) Xavier Vidal et al.   DRUG SAFETY

An Evaluation of Three Signal-Detection Algorithms Using a Highly Inclusive Reference Event Database

(2009) Alan M. Hochberg et al.   DRUG SAFETY

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease

(2009) Christianne L. Roumie et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada

(2009) Cristina Varas-Lorenzo et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

(2009) Gianluca Trifirò et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Nonselective and Cyclooxygenase-2-Selective NSAIDs and Acute Kidney Injury

(2008) Wolfgang C. Winkelmayer et al.   AMERICAN JOURNAL OF MEDICINE

Risk of Upper Gastrointestinal Tract Bleeding Associated With Selective Serotonin Reuptake Inhibitors and Venlafaxine Therapy

(2008) Francisco J. de Abajo et al.   ARCHIVES OF GENERAL PSYCHIATRY

Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look

(2008) Lucie Opatrny et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The Risk of Acute Myocardial Infarction with Etodolac Is not Increased Compared to Naproxen: A Historical Cohort Analysis of a Generic COX-2 Selective Inhibitor

(2008) John J. Warner et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity

(2008) James D. Lewis et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY